Product
SHP674
1 clinical trial
1 indication
Indication
Acute Lymphoblastic LeukemiaClinical trial
A Phase 2 Clinical Study of SHP674 in Patients With Newly Diagnosed, Untreated Acute Lymphoblastic LeukemiaStatus: Completed, Estimated PCD: 2021-02-12